Literature DB >> 8630400

The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.

A Cambiaggi1, A M Orengo, R Meazza, S Sforzini, P L Tazzari, F Lauria, D Raspadori, R Zambello, G Semenzato, L Moretta, S Ferrini.   

Abstract

Four patients with lymphoproliferative disease of granular lymphocytes (LDGL) coexpressing CD3 and the natural killer (NK)-related "p58" receptor for HLA-C alleles were studied. These CD3+p58+ LDGLs have been detected among a series of 44 CD3+ LDGLs analyzed. Two patients with LDGL (GI and BA) expressed only the p58 molecule defined by the GL-183 and CH-L monoclonal antibodies (MoAbs), while the cases of patients PU and MA also coexpressed the molecular form identified by EB6 anti-p58 MoAb. Three LDGL cases (GI, MA, and PU) displayed the CD8+4-CD16+ T-cell receptor (TCR)alpha/beta+ phenotype, while one patient (BA) was CD8+4+CD16+ TCRalpha/beta+. Freshly isolated granular lymphocytes (GL) from these cases displayed cytolytic activity in an anti-CD3 MoAb-triggered redirected killing assay against the Fcgamma-receptor+ (Fcgamma-R+) P815 target cell line. Lysis of P815 target cells, triggered by an anti-CD3 or by anti-CD16 MoAb, could be inhibited by the addition of anti-p58 MoAb in three fresh or interleukin (IL)-2-cultured GL tested (GI, MA, and PU). Triggering of cytotoxicity against the HLA-DR+ Fcgamma-R+ Daudi cell line induced by appropriate superantigens could also be inhibited by anti-p58 MoAb in patients PU and GI with LDGL. These data indicate that activation through the CD16, CD3, and TCR molecules can be modulated by p58 receptors in these LDGLs. On the contrary, IL-2-expanded cells of patient BA were induced to lyse P815 target cells by anti-p58 MoAb. In addition, anti-p58 MoAB enhanced anti-CD16 MoAb triggered lysis and did not inhibit activation via CD3. These data indicate that, in this particular patient with LDGL, p58 displays a stimulatory effect on cell triggering, rather than the typical inhibitory effect previously observed in p58+ T-cell clones derived from healthy donors. The anti-p58 MoAb did not induce CA++ mobilization in p58+ LDGLs and in a p58+CD3+ normal T-cell clone equipped with inhibitory p58 molecules, while Ca++ mobilization could be observed in cultured GL from patient BA, which could be activated by anti-58 MoAb. These findings suggest that stimulatory and inhibitory p58 molecules are equipped with different signal transducing properties, thus contributing to a better knowledge of the normal counterpart.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630400

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  HLA-C revisited. Ten years of change.

Authors:  C S Falk; D J Schendel
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 2.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

3.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

4.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  Effect of recombinant cytokines on the expression of natural killer cell receptors from patients with TB or/and HIV infection.

Authors:  Venkata Ramana Rao Parasa; Rajasekaran Sikhamani; Alamelu Raja
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

6.  Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor.

Authors:  Raynier Devillier; Boris Calmels; Sophie Guia; Mohammed Taha; Cyril Fauriat; Bechara Mfarrej; Geoffroy Venton; Eric Vivier; Daniel Olive; Christian Chabannon; Didier Blaise; Sophie Ugolini
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

7.  Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.

Authors:  Sylvain Carras; Dimitri Chartoire; Sylvain Mareschal; Maël Heiblig; Antoine Marçais; Rémy Robinot; Mirjam Urb; Roxane M Pommier; Edith Julia; Amel Chebel; Aurélie Verney; Charlotte Bertheau; Emilie Bardel; Caroline Fezelot; Lucien Courtois; Camille Lours; Alyssa Bouska; Sunandini Sharma; Christine Lefebvre; Jean-Pierre Rouault; David Sibon; Anthony Ferrari; Javeed Iqbal; Laurence de Leval; Philippe Gaulard; Alexandra Traverse-Glehen; Pierre Sujobert; Mathieu Blery; Gilles Salles; Thierry Walzer; Emmanuel Bachy; Laurent Genestier
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.